See featured analyses conducted by our center community and colleagues here.
Cancer Prevention Guidelines
Jane Kim and her team led a decision analysis to inform the revision of US Preventive Services Task Force (USPSTF) cervical cancer screening guidelines, using new data on standalone human papillomavirus (HPV) testing for women ages 25 and older. Learn more about the U.S. Preventive Services Task Force here.
High Value Options for Stroke
Ankur Pandya is using cost-effectiveness analysis to identify high-value policies for preventing and treating stroke. The health and economic consequences of stroke in the U.S. are profound, and expected to escalate further with population aging. Policy makers, providers, and patients will face inevitable tradeoffs.
FREQUENTLY ASKED QUESTIONS
How does cost-effectiveness analysis differ from benefit-cost analysis?
What is the difference between cost-effectiveness and affordability?
For example, a train pass could be cost-effective if the alternative is driving your own gas-guzzling car, but it might not be affordable if it costs $200 to purchase whereas your car has a full tank of gas at the moment.
Is a budget impact analysis a cost-effectiveness analysis?